Teradyne Lost 17% in a Week. UBS Still Sees 61% Upside
Teradyne (TER) fell 17% in a week despite Q3 revenue beating estimates at $1.31B, up 70%. Q4 guidance expects flat revenue around $1.3B. UBS cut its target to $430 but maintains a Buy rating, citing 65% upside from Monday's close.
How this was made
The 30-second read
Why it matters
The earnings beat was offset by a flat Q4 outlook, prompting analysts to lower price targets and the stock to slide 17% in a week.
Market read
The earnings release and guidance revision are the primary catalysts for the recent price move, making the article highly relevant for short‑term traders.
What to watch
Potential new AI contracts later in the year could reignite growth, and the stock trades below its five‑year average multiple.
Background
Teradyne is a leading supplier of automated test equipment for semiconductor and AI applications.
Ticker impact
Teradyne reported Q3 revenue up 70% and beat EPS, but its Q4 guidance flat at $1.3B triggered a 17% price drop.
downward pressure as investors price in the flat guide, unless valuation multiples expand.
The guide shows no sequential growth, which is a key driver for AI‑test equipment makers; analysts cut targets, indicating near‑term weakness.
Market effects
AI test equipment sector may see broader scrutiny as investors reassess growth forecasts.
U.S. technology stocks could face modest pullback in the afternoon session.
Limited to investors tracking AI‑related hardware; no immediate global macro effect.
Counterpoint
UBS still sees 61% upside, suggesting the stock may be oversold if valuation multiples recover.
Key entities
- CompanyTeradyne
Provider of test equipment; ticker TER.
- AnalystUBS
Reduced target price to $430, maintaining a Buy rating.
